BackAprogen Medicines Overview

Aprogen Medicines Goodwill

Track Aprogen Medicines's goodwill ($51B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$50.96B
↑ 10.89% YoYΔ $5.00B vs prior year quarter

Peer trimmed avg / median

Loading

Aprogen Medicines Goodwill History

Loading

Aprogen Medicines vs. peers: Goodwill Comparison

Loading

Aprogen Medicines Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aprogen Medicines (007460.KS) FAQ

Aprogen Medicines's goodwill stands at $51B as of June 2026. That compares with $46B in the prior-year period — up 10.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Aprogen Medicines reported $51B in goodwill versus $46B a year earlier — a 10.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $46B in the prior-year period — up 10.9% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Aprogen Medicines's goodwill evolved across reporting periods, while the comparison chart places 007460.KS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.